33M, Skullet guy here, 3 months on 1mg Finasteride, 2 months on 5% Minoxidil, and about a month and a half of derma rolling. Progress Pictures 2/14/2026
A 33-year-old man is experiencing positive hair regrowth after 3 months on 1mg finasteride, 2 months on 5% minoxidil, and 1.5 months of derma rolling. He is hopeful for further progress and considering additional treatments like dutasteride and microneedling.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity My temples after 2.5 months on oral fin/dut, ketoconazole shampoo, minoxidil, tretinoin and dermarolling
The user shared progress pictures showing improved hair growth at the temples after 2.5 months using oral finasteride/dutasteride, ketoconazole shampoo, minoxidil, tretinoin, and dermarolling. The user reported no side effects from the medications and noted inconsistent microneedling.
community What would you rank the most effective tool following mino, fin and dermarolling?
The conversation discusses various hair loss treatments, including minoxidil, finasteride, dutasteride, RU58841, microneedling, ketoconazole shampoo, and laser therapy. Users emphasize the importance of consistency, patience, and individual response to treatments.
community How much do you wait after dermarolling to apply Minoxidil?
There is no consensus on how long to wait after dermarolling before applying Minoxidil, with some applying immediately and others waiting up to 24 hours. Users report varying experiences with side effects, and some also use finasteride or dutasteride in their hair loss treatment routines.
community 6 MONTH PROGRESS - NO CHANGE AT ALL - Minoxidil/Daily Dermarolling/Vitamine D3
The user saw no hair regrowth after six months using minoxidil, daily dermarolling, and vitamin D3. Many suggest adding finasteride or dutasteride for better results.
community 24yo no progress 6 months fin + min
A 24-year-old has been using oral finasteride and topical minoxidil for six months with minimal progress in hair regrowth, despite starting derma rolling and considering telogen effluvium as a possible cause. Suggestions include switching to oral minoxidil, adding dutasteride, and continuing microneedling for better results.
Related Research
6 / 6 resultsresearch Status of research on the development and regeneration of hair follicles
This review examines the mechanisms of hair follicle development and regeneration, discussing current hair loss treatments and emerging therapies like low-level laser therapy and stem cell therapy, which the authors suggest show promise in managing hair loss.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.
research Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
This review discusses advanced biomedical technologies, such as nanotechnology and stem cell-based approaches, for treating androgenetic alopecia, detailing their benefits, current applications, and challenges, without reporting new experimental results.
research Cosmetic Procedures in the Treatment of Alopecia
This review discusses various treatments for noncicatricial alopecias, such as androgenetic alopecia and alopecia areata, including mesotherapy, microneedling, and platelet-rich plasma therapy, noting that outcomes vary across these procedures.
research Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis
This study found that combined microneedling with minoxidil significantly improved hair count and diameter in patients with androgenetic alopecia, although more mild adverse events were reported compared to minoxidil alone.
research Genomic Markers and Personalized Medicine in Androgenetic Alopecia: A Comprehensive Review
This review discusses genetic and pharmacogenetic insights, along with RNA interference technologies, for developing personalized therapies for androgenetic alopecia, yet presents no new clinical results.